BTW
WST icon

Boston Trust Walden’s West Pharmaceutical WST Stock Holding History

Boston Trust Walden’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.2M Buy
+81,231
New +$24.8M 0.22% 153
2025
Q2 		– Sell
-1,110
Closed -$249K – 384
2025
Q1 		$249K Buy
1,110
+50
+5% +$13.8K ﹤0.01% 359
2024
Q4 		$347K Sell
1,060
-50
-5% -$15.7K ﹤0.01% 341
2024
Q3 		$333K Hold
1,110
– – ﹤0.01% 341
2024
Q2 		$366K Sell
1,110
-100
-8% -$35.3K ﹤0.01% 336
2024
Q1 		$479K Sell
1,210
-12,237
-91% -$4.53M ﹤0.01% 317
2023
Q4 		$4.73M Sell
13,447
-4,421
-25% -$1.56M 0.04% 224
2023
Q3 		$6.7M Sell
17,868
-227
-1% -$87.8K 0.06% 211
2023
Q2 		$6.92M Sell
18,095
-11,815
-40% -$4.22M 0.06% 214
2023
Q1 		$10.4M Sell
29,910
-4,605
-13% -$1.35M 0.09% 197
2022
Q4 		$8.12M Buy
+34,515
New +$8.18M 0.07% 212
2016
Q3 		– Sell
-34,829
Closed -$2.64M – 348
2016
Q2 		$2.64M Sell
34,829
-205,623
-86% -$15M 0.05% 250
2016
Q1 		$16.7M Sell
240,452
-83,418
-26% -$5.02M 0.29% 138
2015
Q4 		$19.5M Sell
323,870
-493,173
-60% -$29.7M 0.36% 107
2015
Q3 		$44.2M Sell
817,043
-34,554
-4% -$2.01M 0.74% 33
2015
Q2 		$49.5M Sell
851,597
-266,335
-24% -$14.9M 0.75% 30
2015
Q1 		$67.3M Sell
1,117,932
-69,104
-6% -$3.68M 1% 14
2014
Q4 		$63.2M Sell
1,187,036
-238,189
-17% -$11.9M 0.94% 17
2014
Q3 		$63.8M Sell
1,425,225
-66,922
-4% -$2.84M 0.99% 13
2014
Q2 		$62.9M Buy
1,492,147
+19,516
+1% +$836K 0.91% 16
2014
Q1 		$64.9M Sell
1,472,631
-31,115
-2% -$1.46M 0.96% 12
2013
Q4 		$73.8M Sell
1,503,746
-72,435
-5% -$3.39M 1.08% 6
2013
Q3 		$64.9M Sell
1,576,181
-50,173
-3% -$1.91M 0.99% 9
2013
Q2 		$57.1M Buy
+1,626,354
New +$53.5M 0.92% 17

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Boston Trust Walden's WST Position: Q2 2026 in Review

Boston Trust Walden opened a new position in West Pharmaceutical (WST) in Q2 2026: 81,231 shares worth $29.2M. The stake represents 0.22% of the portfolio and ranks #153 among its holdings. This is a return to the name: Boston Trust Walden previously reported a position in WST as recently as Q1 2025.

Boston Trust Walden first reported a position in WST in Q2 2013 and has held it in 24 quarters since. The position peaked at $73.8M in Q4 2013. 305 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Boston Trust Walden held 81,231 shares of West Pharmaceutical worth $29.2M as of Q2 2026.
  • West Pharmaceutical was a new Boston Trust Walden position in Q2 2026.
  • West Pharmaceutical made up 0.22% of Boston Trust Walden's portfolio in Q2 2026, its #153 holding.
  • Boston Trust Walden first reported a position in West Pharmaceutical in Q2 2013 and has held it in 24 quarters since.
  • Boston Trust Walden's West Pharmaceutical position peaked at $73.8M in Q4 2013.
  • 305 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.